Eli Lilly and Company

Senior / Principal Process Engineer - APIEM

Paris, Île-de-France, France

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in Chemical Engineering or a related field, with a minimum of 10 years of experience in process engineering, preferably within the pharmaceutical or biotechnology industry. Strong understanding of pharmaceutical manufacturing processes, GMP regulations, and process validation principles is essential. Experience with API manufacturing, specifically in solid dosage forms, is highly desirable. Demonstrated ability to interpret and apply technical documentation, including batch records, SOPs, and validation protocols, is required.

Responsibilities

The Senior / Principal Process Engineer - APIEM will provide technical leadership and expertise to API EM contract manufacturer personnel, ensuring the reliable supply and commercialization of medicines. This includes on-site technical presence at the CM, overseeing manufacturing execution, supporting major investigations and troubleshooting, and developing process knowledge. The role involves collaborating with CM personnel on equipment specification, procurement, and IQ/OQ/PQ, as well as assessing HSE and PSM elements impacting Lilly products. Additionally, the engineer will coach and mentor process team members, support root cause analysis, develop process knowledge infrastructure, and provide process & equipment support to identify systemic issues and drive continuous improvement activities.

Skills

Process Engineering
Validation
Troubleshooting
Operational Control Strategy
Equipment Specification
IQ/OQ/PQ
HSE
Manufacturing Execution
Risk Assessment
Team Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI